O

Option Care Health

Largest independent home infusion therapy provider

Warehouse Pharmacy Technician

Full-TimePosted on 7/30/2026
$16.66 - $27.75
Entry
Associate's
Columbia, MD, USA
In Person

About the job

Requirements
  • A high school diploma or equivalent is required.
  • Must have a valid driver's license, maintain a driving record that meets company standards, and maintain auto insurance at all times.
  • Must meet all state requirements for a Pharmacy Technician, which may include registration, licensure, or certification.
  • Must remain aware of the supervisory pharmacist's role and responsibility for medication integrity during preparation, storage, and shipping.
  • Must know the geography serviced by the Pharmacy, traffic patterns, and drive times.
  • Must understand all service options and delivery time commitments.
  • Must know accreditation standards and requirements.
  • Must be able to read, analyze, and interpret operational logistics functions appropriate to assigned duties and responsibilities; operate information systems; follow policy; complete required forms; and prepare reports.
  • Must be able to perform basic mathematical calculations.
  • Must be able to identify problems, collect data, establish facts, and contribute toward valid conclusions.
Responsibilities
  • Develop a positive working rapport with courier services, where applicable, and understand their response times, delivery protocols, after-hours service, and compliance with applicable regulations, HIPAA, and ACHC.
  • When applicable, maintain the assigned vehicle in clean and orderly condition inside and outside, report mechanical problems to a supervisor, and develop an alternate delivery plan in case of an emergency breakdown.
  • Gather and check compounding materials before they enter the clean room.
  • Compound sterile preparations as needed.
  • Check final products for particulate matter and container integrity before presenting them to a pharmacist for final check.
  • Label compounded sterile preparations when permitted by state regulations.
  • Check ancillary supplies.
  • Pick and pack supplies.
  • Develop efficient territory management and delivery zones; coordinate with customer service and Pharmacy to facilitate timely processing of delivery tickets and compounding documents; use the most cost-effective delivery method; track and trend delivery-ticket lead time; and coordinate with Pharmacy Technicians to prioritize the mix schedule for efficient deliveries and timely commitments.
  • Use delivery and warehouse best practices, maintain a safe work environment and practices, and track and trend cost per delivery.
  • Assist in orienting new warehouse team members.
  • Participate in the inventory count process through final reporting.
  • Maintain the warehouse safely.
  • Facilitate efficient workflow processes and inventory stocking.
  • Assemble and prepare patient deliveries.
  • Receive and stock incoming orders.
  • Perform routine maintenance, testing, and cleaning of returned equipment.
  • Perform inventory control, rotate stock as necessary, and notify appropriate personnel of stock shortages promptly.
  • Accurately compile ordered medication, supplies, equipment, and associated documentation for delivery, and obtain a supervisory cross-check of the compiled order.
  • Adhere to company performance programs, policies, procedures, guidelines, and internal control standards, and understand the internal control procedures applicable to assigned job functions.
  • Report concerns about deficiencies in internal controls.
  • Perform other duties as assigned.
Desired Qualifications
  • An associate's degree is preferred.
  • One year of experience in warehouse, distribution, inventory, and healthcare is preferred.
  • For Texas: Pharmacy Technician registration is preferred; Pharmacy Technician-in-training status is required.
  • For Ohio: Pharmacy Technicians must be registered; technicians may pick, label, and pack non-compounded drugs but may not perform duties related to sterile compounding.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.

Yahoo Finance
Jun 9th, 2026
Goldman Sachs initiates Option Care Health coverage with neutral rating, $22 price target

Option Care Health shares rose 3.5% after Goldman Sachs initiated coverage with a Neutral rating and a $22 price target, suggesting potential upside from the stock's recent price of $20.51. The move comes after the stock declined 33% over the previous six months. Whilst Goldman Sachs took a cautious stance, other firms including Deutsche Bank and UBS maintain Buy ratings on the stock. The company recently reported weak first-quarter 2026 results, with revenue of $1.35 billion missing forecasts despite a 1.3% year-on-year increase. Option Care Health also lowered its full-year revenue guidance to $5.73 billion, below analyst estimates. The stock is down 35.5% year-to-date and trading 43.2% below its 52-week high.

INACTIVE